DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Significant Ownership

Signature - Title
Flynn Management LLC, its general partner - Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).

Significant Ownership of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRY ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 10.72% $126M 10.5M Deerfield Management Company, L.P. Mar 20, 2025
PHGE BiomX Inc. Common Stock, par value $0.0001 per share 9.99% $11.4M 15.6M Deerfield Management Company, L.P. Feb 27, 2025

Schedules 13D/G Reported by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C):

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.